As an example of potential clinical application, the VeCare device was applied to assay TNF-α, IL-6, IL-8, TGF-β1, S. aureus, and pH in wound fluids collected from five patients with active venous ulcers, once a week for five consecutive weeks. This evidence concerns the gene CXCL8 and varicose ulcer.